Xvivo Perfusion AB
XVIVO.ST
#5124
Rank
$1.26 B
Marketcap
$40.03
Share price
-1.23%
Change (1 day)
63.91%
Change (1 year)
Categories

Revenue for Xvivo Perfusion AB (XVIVO.ST)

Revenue in 2024 (TTM): $65.99 Million USD

According to Xvivo Perfusion AB's latest financial reports the company's current revenue (TTM ) is $65.99 Million USD. In 2023 the company made a revenue of $56.7 Million USD an increase over the revenue in the year 2022 that were of $40.6 Million USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Xvivo Perfusion AB from 2013 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) $65.99 M16.39%
2023 $56.7 M39.66%
2022 $40.6 M38.17%
2021 $29.38 M46.78%
2020 $20.02 M-14.61%
2019 $23.44 M9.85%
2018 $21.34 M21.14%
2017 $17.61 M9.17%
2016 $16.13 M12.79%
2015 $14.3 M19.74%
2014 $11.94 M12.81%
2013 $10.59 M